Who
Karen S. Lynch
Director
Company insider
Files Form 4 as: Director, Thermo Fisher Scientific; Director, Automatic Data Processing; President and CEO, CVS Health; Director, U.S. Bancorp; President, Aetna Inc /pa/; President, Magellan Health Services; Pres. Grp Ins Dntl Vis & Pharm, Cigna.
In numbers
- Trades disclosed
- 241
- Buys
- 2
- Sells
- 14
- Bought
- $1.2M
- Sold
- $19.7M
- Companies
- 7
- Companies where not an officer
- 3
- First trade
- 22 Feb 2006
- Last trade
- 26 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Sep 2026filed 29 Sep 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —46.3 | filing |
| 26 Sep 2026filed 29 Sep 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —46.3 | filing |
| 27 Jun 2026filed 30 Jun 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —60.91 | filing |
| 27 Jun 2026filed 30 Jun 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —60.91 | filing |
| 20 May 2026filed 22 May 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code A | —499 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code A | —499 at $0.00 | filing |
| 28 Mar 2026filed 31 Mar 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —66.02 | filing |
| 28 Mar 2026filed 31 Mar 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —66.02 | filing |
| 31 Dec 2025filed 5 Jan 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —53.93 | filing |
| 31 Dec 2025filed 5 Jan 2026 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —53.93 | filing |
| 12 Nov 2025filed 14 Nov 2025 | ADP Automatic Data ProcessingPayments & Processors | SEC FORM 4 Code A | —1,453 at $0.00 | filing |
| 27 Sep 2025filed 30 Sep 2025 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —67.31 | filing |
| 28 Jun 2025filed 1 Jul 2025 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —76.54 | filing |
| 21 May 2025filed 22 May 2025 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code A | —565 at $0.00 | filing |
| 29 Mar 2025filed 1 Apr 2025 | TMO Thermo Fisher Scientificoption or derivative · Life-science tools | SEC FORM 4 Code A | —27.69 | filing |
| 19 Feb 2025filed 21 Feb 2025 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code A | —95 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $15.0M188,087 at $79.56 | filing |
| 1 Apr 2024filed 3 Apr 2024 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $3.6M45,248 at $79.56 | filing |
| 1 Apr 2024filed 3 Apr 2024 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code F | $4.9M61,953 at $79.56 | filing |
| 12 Feb 2024filed 14 Feb 2024 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | —136,640 at $0.00 | filing |
News
Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and moreCVS · seekingalpha.com · 16 Oct 2026CVS Health: CVS Caremark Is Transforming the Health Care ExperienceCVS · finanznachrichten.de · 16 Oct 2026CVS Health - Early Detection Matters: Finding Heart Health Risks EarlierCVS · finanznachrichten.de · 15 Oct 2026
0 headlines in the last 90 days name Karen S. Lynch; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.